NSCLC patients with mutations of NTRK family and its three subtypes, NTRK1, NTRK2 and NTRK3, were analyzed, and it was discovered that the overall NTRK mutations or three subtypes were associated with comparable or longer patient OS with ICIs treatment compared to WT. The gene discussed is NTRK2; the disease is non-small cell lung carcinoma.